FDA Panel Likes Janssen Diabetes Drug

(MedPage Today) -- After a day of deliberations, an FDA advisory committee concluded that the agency should approve Invokana (canagliflozin), a novel agent for type 2 diabetes.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news